logo

For the Inventor, By the Inventor

Cincinnati, OH, United States of America

Merrell Dow Pharmaceuticals


USPTO Granted Patents = 455


Trademarks = 9

Forward Citations = 3,534

Loading Chart...
Loading Chart...

221 inventors (with patents filed for the assignee):

goldMedal Richard C Dage (47 out of 52 patents)

silverMedal Richard A Schnettler (40 out of 42 patents)

bronzeMedal Gary A Flynn (32 out of 81 patents)

4.  Norton P Peet (28 out of 87 patents)

5.  Winton D Jones (28 out of 35 patents)

6.  John M Kane (26 out of 49 patents)

7.  James R McCarthy (26 out of 79 patents)

8.  Albert A Carr (24 out of 77 patents)

9.  Francis P Miller (22 out of 26 patents)

10.  Sai P Sunkara (20 out of 25 patents)

11.  Michael G Palfreyman (20 out of 24 patents)

12.  Philippe Bey (20 out of 46 patents)

13.  Ian A McDonald (19 out of 57 patents)

14.  J Martin Grisar (19 out of 34 patents)

15.  Donald Paul Matthews (17 out of 51 patents)


Core Competencies:
Indane Derivatives
Aminoacetylmercapto Derivatives
Immunosuppressants
NMDA Antagonists
Cyclic Nitrone Compounds
Enkephalinase Inhibitors
Tricyclic Derivatives
Anticancer Agents
Glucohydrolase Inhibitors
Serotonin Receptor Agents
Radioprotective Agents
Antiproliferative Oligomers

455 patents:

1. 5529996 - 2-substituted indane-2-mercaptoacetylamide derivatives useful as (1996-06-25),
2. 5529995 - Aminoacetylmercapto derivatives useful as inhibitors of enkephalinase (1996-06-25),
3. 5525633 - Triaryl-ethylene derivatives (1996-06-11),
4. 5514688 - Carbocyclic adenosine analogs useful as immunosuppressants (1996-05-07),
5. 5512177 - Narrow poly- and mono-dispersed anoinic oligomers, and their uses, (1996-04-30),
6. 5504078 - .alpha.-glucosidase inhibitors (1996-04-02),
7. 5500419 - NMDA antagonists (1996-03-19),
8. 5498778 - Cyclic nitrone compounds useful in treating stroke (1996-03-12),
9. 5494932 - Sulfonic stilbene derivatives in the treatment of viral disease (1996-02-27),
10. 5491153 - 3-amidoindolyl derivative (1996-02-13),
11. 5491143 - Mercaptoacetylamide derivatives useful as inhibitors of enkephalinase (1996-02-13),
12. 5491142 - 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful (1996-02-13),
13. 5491141 - 2-substituted indane-2-mercaptoacetylamide tricyclic derivatives useful (1996-02-13),
14. 5491136 - 2,19-methyleneoxy and 2,19-methylenethio bridged steroids as aromatase, (1996-02-13),
15. 5489579 - Potentation of NMDA antagonists (1996-02-06),
Merrell Dow Pharmaceuticals is a global pharmaceutical company that focuses on the development, manufacturing, and marketing of innovative healthcare solutions. With a rich history spanning several decades, we are committed to improving human health and well-being. Our portfolio includes a wide range of therapeutic areas including cardiovascular, respiratory, infectious diseases, and more. Visit our website to learn more about our products, research initiatives, and commitment to quality and patient care.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

455 Patents

#4 in Cincinnati, OH

#40 in Ohio

#1,013 in US

#2,027 in the World

...
Cincinnati, OH, United States of America

Merrell Dow Pharmaceuticals

Forward Citations = 3,534

221 inventors:

goldMedal Richard C Dage (47 out of 52 patents)

silverMedal Richard A Schnettler (40 out of 42 patents)

bronzeMedal Gary A Flynn (32 out of 81 patents)

4.  Norton P Peet (28 out of 87 patents)

5.  Winton D Jones (28 out of 35 patents)

Please report any incorrect information to support@idiyas.com
Loading…